Contact us
Home / News Center / Business

Business

Filters
Filters
Category
Search
Show (50)
Cancel
GMP0512
Business, Investors

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations for $122.5M

This acquisition establishes a 20,000-liter U.S. biologics drug substance manufacturing

V3
Business, Events

Bora Pharmaceuticals Named TIME’s Inaugural World’s Most Impactful Companies 2026 Top 500

Strengthening Supply Chain Resilience and Expanding Patient Access Through a

GMP0512
Business, Investors

Bora Group to Acquire MacroGenics’ GMP Manufacturing Operations for $122.5M, Securing Maryland-Based Drug-Substance Facility and Existing Commercial Orders to Scale the Group’s Integrated Technology Platform

Taipei, Taiwan, May 12, 2026 – Bora Pharmaceuticals (“Bora” or

Banner announcing SunWay Biotech to acquire Weider Global Nutrition, with logos for SunWay Biotech and Weider Global Nutrition.
Business, Investors

Bora Group Accelerates Nutraceutical Substance CDMO Investments and Global Channel Build-Out For Brand Business

Subsidiary Sunway Biotech to Acquire Weider Global Nutrition Acquisition Completes

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Business, Investors

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Bora manufactures more than 20 commercial products for GSK at

Bora-Zhunan-2-r9rm43l1jaffg866ioruef5763z1vbjprjfkrv6o6k
Business, Investors

Bora Pharmaceuticals’ Zhongli Facility Approved as a Bonded Factory, Advancing Supply Chain Efficiency

Taipei, Taiwan, February 23, 2026 – Bora Pharmaceuticals Co., Ltd.

Bora-Zhunan-2-r9rm43l1jaffg866ioruef5763z1vbjprjfkrv6o6k
Business

Bora Pharmaceuticals to Sponsor “Berkeley Dialogue” in Taipei, Advancing the Biopharma R&D and Supply Chain

Bora to discuss a recent collaboration with Therapi AI, highlighting

cropped-image (18)
Business

Bora Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

Taipei, Taiwan, January 22, 2026 – Bora Pharmaceuticals Co., Ltd.

ADR Web
Business, Investors

OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX

NEW YORK, (January 8, 2026) –OTC Markets Group Inc. (OTCQX:

Bora Web Cover Banner (3)
Business

Bora Pharmaceuticals Advances Governance and Carbon Reduction to Power Its Sustainability Ambition and Enhance Global CDMO Capabilities

Taipei, Taiwan, (December 12, 2025) – Bora Pharmaceuticals Co., Ltd.

Bora + Corealis
Business

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development

Partnership creates simplified pathway from early development to commercial launch

bora2
Business

Bora Pharmaceuticals Marks Five Years in Mississauga, Canada, Strengthening Its Commitment to Onshore and Global CDMO Excellence 

Milestone reflects the company’s continued impact in providing global pharmaceutical